Skip to main content
. Author manuscript; available in PMC: 2013 Oct 17.
Published in final edited form as: Ther Adv Cardiovasc Dis. 2012 Jan 5;6(1):15–29. doi: 10.1177/1753944711434039

Figure 2.

Figure 2

Changes in mean arterial pressure and heart rate in the three groups. There are no significant differences of mean arterial pressure in three groups at baseline (C1–C3). However, after treatment (T12–T14), mean arterial pressure was reduced by valsartan and further reduced by the addition of aliskiren to the valsartan treatment. There were no significant differences of heart rate in three groups both at baseline (C1–C3) and after treatment (T12–T14). ***: P<0.001 vs. C1 to C3, +++: P<0.001 vs. Vehicle, ###: P<0.001 vs. Valsartan.